 | • レポートコード：D0GIR-06489 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオ工学によるタンパク質医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオ工学によるタンパク質医薬品の種類別市場規模（組換えタンパク質医薬品、ペプチドホルモン、ワクチン、治療酵素、モノクローナル抗体、サイトカイン、代替タンパク質、ペプチド抗生物質、血液製剤）、用途別市場規模（分別、バイオリアクター・微生物細胞発酵、遺伝子工学、遺伝子組換え生物、ファーミング、遺伝子組換え微生物・植物・動物生産バイオ工学によるタンパク質医薬品、細胞培養、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abbot、Hoffman-la-Roche、Bayer、Amgen、Fresenius Kabi、Baxter、Merck、GlaxoSmithKline、Eli Lilly、Johnson & Johnson ・地域別グローバル市場分析 2015年-2020年 ・バイオ工学によるタンパク質医薬品の北米市場（アメリカ、カナダ、メキシコ） ・バイオ工学によるタンパク質医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオ工学によるタンパク質医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオ工学によるタンパク質医薬品の南米市場（ブラジル、アルゼンチン） ・バイオ工学によるタンパク質医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：組換えタンパク質医薬品、ペプチドホルモン、ワクチン、治療酵素、モノクローナル抗体、サイトカイン、代替タンパク質、ペプチド抗生物質、血液製剤 ・用途別分析：分別、バイオリアクター・微生物細胞発酵、遺伝子工学、遺伝子組換え生物、ファーミング、遺伝子組換え微生物・植物・動物生産バイオ工学によるタンパク質医薬品、細胞培養、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Bioengineered Protein Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 100270 million by 2025, from USD 86200 million in 2019.
The Bioengineered Protein Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Bioengineered Protein Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Bioengineered Protein Drugs market has been segmented into
Recombinant protein drugs
Peptide hormones
Vaccines
Therapeutic enzymes
Monoclonal antibodies
Cytokines
Replacement proteins
Peptide antibiotics
Blood products
By Application, Bioengineered Protein Drugs has been segmented into:
Fractionation
Bioreactors and microbial cell fermentation
Genetic engineering
Genetically modified organisms
Pharming
Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
Cell culture
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bioengineered Protein Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Bioengineered Protein Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bioengineered Protein Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Bioengineered Protein Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Bioengineered Protein Drugs Market Share Analysis
Bioengineered Protein Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bioengineered Protein Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bioengineered Protein Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Bioengineered Protein Drugs are:
Abbot
Hoffman-la-Roche
Bayer
Amgen
Fresenius Kabi
Baxter
Merck
GlaxoSmithKline
Eli Lilly
Johnson & Johnson
Among other players domestic and global, Bioengineered Protein Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bioengineered Protein Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bioengineered Protein Drugs, with price, sales, revenue and global market share of Bioengineered Protein Drugs in 2018 and 2019.
Chapter 3, the Bioengineered Protein Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioengineered Protein Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Bioengineered Protein Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Bioengineered Protein Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Bioengineered Protein Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bioengineered Protein Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Recombinant protein drugs
1.2.3 Peptide hormones
1.2.4 Vaccines
1.2.5 Therapeutic enzymes
1.2.6 Monoclonal antibodies
1.2.7 Cytokines
1.2.8 Replacement proteins
1.2.9 Peptide antibiotics
1.2.10 Blood products
1.3 Market Analysis by Application
1.3.1 Overview: Global Bioengineered Protein Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Fractionation
1.3.3 Bioreactors and microbial cell fermentation
1.3.4 Genetic engineering
1.3.5 Genetically modified organisms
1.3.6 Pharming
1.3.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
1.3.8 Cell culture
1.3.9 Others
1.4 Overview of Global Bioengineered Protein Drugs Market
1.4.1 Global Bioengineered Protein Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbot
2.1.1 Abbot Details
2.1.2 Abbot Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbot SWOT Analysis
2.1.4 Abbot Product and Services
2.1.5 Abbot Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hoffman-la-Roche
2.2.1 Hoffman-la-Roche Details
2.2.2 Hoffman-la-Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hoffman-la-Roche SWOT Analysis
2.2.4 Hoffman-la-Roche Product and Services
2.2.5 Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Fresenius Kabi SWOT Analysis
2.5.4 Fresenius Kabi Product and Services
2.5.5 Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Baxter
2.6.1 Baxter Details
2.6.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Baxter SWOT Analysis
2.6.4 Baxter Product and Services
2.6.5 Baxter Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly SWOT Analysis
2.9.4 Eli Lilly Product and Services
2.9.5 Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson & Johnson SWOT Analysis
2.10.4 Johnson & Johnson Product and Services
2.10.5 Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Bioengineered Protein Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Bioengineered Protein Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Bioengineered Protein Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Bioengineered Protein Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Bioengineered Protein Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Bioengineered Protein Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
4.5 South America Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Bioengineered Protein Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Bioengineered Protein Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Bioengineered Protein Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Bioengineered Protein Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Bioengineered Protein Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
6.3 UK Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
6.4 France Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Bioengineered Protein Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
7.5 India Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Bioengineered Protein Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Bioengineered Protein Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Bioengineered Protein Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Bioengineered Protein Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Bioengineered Protein Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Bioengineered Protein Drugs Price by Type (2015-2020)
11 Global Bioengineered Protein Drugs Market Segment by Application
11.1 Global Bioengineered Protein Drugs Sales Market Share by Application (2015-2020)
11.2 Global Bioengineered Protein Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Bioengineered Protein Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Bioengineered Protein Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Bioengineered Protein Drugs Market Forecast (2021-2025)
12.2.2 Europe Bioengineered Protein Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Bioengineered Protein Drugs Market Forecast (2021-2025)
12.2.4 South America Bioengineered Protein Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Bioengineered Protein Drugs Market Forecast (2021-2025)
12.3 Bioengineered Protein Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Bioengineered Protein Drugs Market Share Forecast by Type (2021-2025)
12.4 Bioengineered Protein Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Bioengineered Protein Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Bioengineered Protein Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bioengineered Protein Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bioengineered Protein Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbot Basic Information, Manufacturing Base and Competitors
Table 8. Abbot Bioengineered Protein Drugs Major Business
Table 9. Abbot Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Abbot SWOT Analysis
Table 11. Abbot Bioengineered Protein Drugs Product and Services
Table 12. Abbot Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hoffman-la-Roche Basic Information, Manufacturing Base and Competitors
Table 14. Hoffman-la-Roche Bioengineered Protein Drugs Major Business
Table 15. Hoffman-la-Roche Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Hoffman-la-Roche SWOT Analysis
Table 17. Hoffman-la-Roche Bioengineered Protein Drugs Product and Services
Table 18. Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Bioengineered Protein Drugs Major Business
Table 21. Bayer Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Bayer SWOT Analysis
Table 23. Bayer Bioengineered Protein Drugs Product and Services
Table 24. Bayer Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Bioengineered Protein Drugs Major Business
Table 27. Amgen Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Amgen SWOT Analysis
Table 29. Amgen Bioengineered Protein Drugs Product and Services
Table 30. Amgen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 32. Fresenius Kabi Bioengineered Protein Drugs Major Business
Table 33. Fresenius Kabi Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Fresenius Kabi SWOT Analysis
Table 35. Fresenius Kabi Bioengineered Protein Drugs Product and Services
Table 36. Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Baxter Basic Information, Manufacturing Base and Competitors
Table 38. Baxter Bioengineered Protein Drugs Major Business
Table 39. Baxter Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Baxter SWOT Analysis
Table 41. Baxter Bioengineered Protein Drugs Product and Services
Table 42. Baxter Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Bioengineered Protein Drugs Major Business
Table 45. Merck Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Merck SWOT Analysis
Table 47. Merck Bioengineered Protein Drugs Product and Services
Table 48. Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Bioengineered Protein Drugs Major Business
Table 51. GlaxoSmithKline Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 52. GlaxoSmithKline SWOT Analysis
Table 53. GlaxoSmithKline Bioengineered Protein Drugs Product and Services
Table 54. GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 56. Eli Lilly Bioengineered Protein Drugs Major Business
Table 57. Eli Lilly Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 58. Eli Lilly SWOT Analysis
Table 59. Eli Lilly Bioengineered Protein Drugs Product and Services
Table 60. Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson Bioengineered Protein Drugs Major Business
Table 63. Johnson & Johnson Bioengineered Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Johnson & Johnson SWOT Analysis
Table 65. Johnson & Johnson Bioengineered Protein Drugs Product and Services
Table 66. Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Bioengineered Protein Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Bioengineered Protein Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Bioengineered Protein Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Global Bioengineered Protein Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Bioengineered Protein Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Bioengineered Protein Drugs Sales by Countries (2015-2020) (K Units)
Table 73. North America Bioengineered Protein Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Bioengineered Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Bioengineered Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Bioengineered Protein Drugs Sales by Countries (2015-2020) (K Units)
Table 77. Europe Bioengineered Protein Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Bioengineered Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Bioengineered Protein Drugs Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Bioengineered Protein Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Bioengineered Protein Drugs Sales by Countries (2015-2020) (K Units)
Table 83. South America Bioengineered Protein Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Bioengineered Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Bioengineered Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Bioengineered Protein Drugs Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Bioengineered Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Bioengineered Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Bioengineered Protein Drugs Sales by Type (2015-2020) (K Units)
Table 91. Global Bioengineered Protein Drugs Sales Share by Type (2015-2020)
Table 92. Global Bioengineered Protein Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Bioengineered Protein Drugs Revenue Share by Type (2015-2020)
Table 94. Global Bioengineered Protein Drugs Sales by Application (2015-2020) (K Units)
Table 95. Global Bioengineered Protein Drugs Sales Share by Application (2015-2020)
Table 96. Global Bioengineered Protein Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Bioengineered Protein Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Bioengineered Protein Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Bioengineered Protein Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Bioengineered Protein Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Bioengineered Protein Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Bioengineered Protein Drugs Picture
Figure 2. Global Sales Market Share of Bioengineered Protein Drugs by Type in 2019
Figure 3. Recombinant protein drugs Picture
Figure 4. Peptide hormones Picture
Figure 5. Vaccines Picture
Figure 6. Therapeutic enzymes Picture
Figure 7. Monoclonal antibodies Picture
Figure 8. Cytokines Picture
Figure 9. Replacement proteins Picture
Figure 10. Peptide antibiotics Picture
Figure 11. Blood products Picture
Figure 12. Bioengineered Protein Drugs Sales Market Share by Application in 2018
Figure 13. Fractionation Picture
Figure 14. Bioreactors and microbial cell fermentation Picture
Figure 15. Genetic engineering Picture
Figure 16. Genetically modified organisms Picture
Figure 17. Pharming Picture
Figure 18. Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Picture
Figure 19. Cell culture Picture
Figure 20. Others Picture
Figure 21. Global Bioengineered Protein Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 22. United States Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Canada Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Mexico Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Germany Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. France Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. UK Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Russia Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Italy Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. China Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Japan Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Korea Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. India Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Southeast Asia Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Australia Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 36. Brazil Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Egypt Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 38. Saudi Arabia Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 39. South Africa Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 40. Turkey Bioengineered Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 41. Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2019
Figure 42. Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2019
Figure 43. Top 3 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2019
Figure 44. Top 6 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2019
Figure 45. Key Manufacturer Market Share Trend
Figure 46. Global Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 47. Global Bioengineered Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. Global Bioengineered Protein Drugs Revenue Market Share by Regions (2015-2020)
Figure 49. Global Bioengineered Protein Drugs Revenue Market Share by Regions in 2018
Figure 50. North America Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
Figure 51. Europe Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
Figure 52. Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
Figure 53. South America Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
Figure 54. Middle East & Africa Bioengineered Protein Drugs Sales and Growth Rate (2015-2020)
Figure 55. North America Bioengineered Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. North America Bioengineered Protein Drugs Sales Market Share by Countries (2015-2020)
Figure 57. North America Bioengineered Protein Drugs Sales Market Share by Countries in 2018
Figure 58. North America Bioengineered Protein Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 59. North America Bioengineered Protein Drugs Revenue Market Share by Countries in 2018
Figure 60. United States Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Canada Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Mexico Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Europe Bioengineered Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Europe Bioengineered Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 65. Europe Bioengineered Protein Drugs Revenue Market Share by Countries in 2019
Figure 66. Germany Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. UK Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. France Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Russia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Italy Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Regions 2019
Figure 73. Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Regions 2019
Figure 74. China Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Japan Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Korea Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. India Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South America Bioengineered Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. South America Bioengineered Protein Drugs Sales Market Share by Countries in 2019
Figure 81. South America Bioengineered Protein Drugs Revenue Market Share by Countries in 2019
Figure 82. Brazil Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Argentina Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Middle East and Africa Bioengineered Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 85. Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Countries in 2019
Figure 86. Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 87. Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries in 2019
Figure 88. Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 89. Egypt Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 90. Turkey Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 91. South Africa Bioengineered Protein Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 92. Global Bioengineered Protein Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 93. Global Bioengineered Protein Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 94. North America Sales Bioengineered Protein Drugs Market Forecast (2021-2025) (K Units)
Figure 95. Europe Sales Bioengineered Protein Drugs Market Forecast (2021-2025) (K Units)
Figure 96. Asia-Pacific Sales Bioengineered Protein Drugs Market Forecast (2021-2025) (K Units)
Figure 97. South America Sales Bioengineered Protein Drugs Market Forecast (2021-2025) (K Units)
Figure 98. Middle East & Africa Sales Bioengineered Protein Drugs Market Forecast (2021-2025) (K Units)
Figure 99. Sales Channel: Direct Channel vs Indirect Channel
組換え治療用抗体・タンパク質の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Recombinant Therapeutic Antibodies and Proteins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 118990 million by 2025, from USD 92080 million in…- ペプチド治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Peptide Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- バイオ工学食品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bioengineered Food market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioengineered Food market …
- 新型コロナウイルス感染症組換えタンパク質ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- インテグリンBeta3タンパク質の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Integrin Beta3 Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…